Nova Mentis Life Science Corp (NOVA.CX)
0.015
0.00 (0.00%)
CAD |
CNSX |
Apr 26, 16:00
Nova Mentis Life Science Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | -1.043M |
| December 31, 2022 | -1.444M |
| September 30, 2022 | -1.787M |
| June 30, 2022 | -1.995M |
| March 31, 2022 | -1.889M |
| December 31, 2021 | -1.946M |
| September 30, 2021 | -1.821M |
| June 30, 2021 | -1.585M |
| March 31, 2021 | -1.299M |
| December 31, 2020 | -0.8565M |
| September 30, 2020 | -0.5965M |
| June 30, 2020 | -0.6799M |
| March 31, 2020 | -0.8035M |
| December 31, 2019 | -0.8788M |
| September 30, 2019 | -1.311M |
| June 30, 2019 | -1.267M |
| March 31, 2019 | -1.137M |
| December 31, 2018 | -1.375M |
| September 30, 2018 | -1.414M |
| June 30, 2018 | -1.479M |
| March 31, 2018 | -1.784M |
| December 31, 2017 | -1.503M |
| September 30, 2017 | -1.291M |
| June 30, 2017 | -1.319M |
| March 31, 2017 | -0.9171M |
| Date | Value |
|---|---|
| December 31, 2016 | -0.7674M |
| September 30, 2016 | -0.6577M |
| June 30, 2016 | -0.5237M |
| March 31, 2016 | -0.5531M |
| December 31, 2015 | -0.7066M |
| September 30, 2015 | -0.4882M |
| June 30, 2015 | -0.6414M |
| March 31, 2015 | -0.7126M |
| December 31, 2014 | -0.4893M |
| September 30, 2014 | -0.4083M |
| June 30, 2014 | -0.1188M |
| March 31, 2014 | -0.0361M |
| December 31, 2013 | -0.1684M |
| September 30, 2013 | -0.1424M |
| June 30, 2013 | -0.1402M |
| March 31, 2013 | -0.133M |
| December 31, 2012 | -0.1331M |
| September 30, 2012 | -0.4294M |
| June 30, 2012 | -0.6191M |
| March 31, 2012 | -1.024M |
| December 31, 2011 | -1.091M |
| September 30, 2011 | -1.262M |
| June 30, 2011 | -1.091M |
| March 31, 2011 | -0.765M |
| December 31, 2010 | -0.7995M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-1.995M
Minimum
Jun 2022
-0.5965M
Maximum
Sep 2020
-1.325M
Average
-1.305M
Median
Cash from Operations (TTM) Benchmarks
| Biocure Technology Inc | -0.4423M |
| Core One Labs Inc | -- |
| Nanosphere Health Sciences Inc | -0.0378M |
| Lobe Sciences Ltd | -2.279M |
| Algernon Pharmaceuticals Inc | -4.059M |